Shares of Evolent Health Inc (Symbol: EVH) recently traded at $5.93, exceeding the average analyst 12-month target price of $5.88. This marks a significant moment for investors, as analysts may adjust their targets or reconsider valuations in response to such movements. Currently, there are 13 different analyst targets, with the highest set at $8.00 and the lowest at $3.00.
Recent ratings from analysts show 11 strong buy, 1 buy, 4 hold, and no sell ratings for Evolent Health. The average rating is 1.56, indicating a generally bullish sentiment, although this has slightly declined from a rating of 1.41 a few months ago.
The standard deviation among targets is $1.325, reflecting varied analyst expectations, and suggesting that investors should assess their strategies as the stock approaches its average target price.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
